Department of Obstetrics Gynecology

Medicine & Life Sciences

1. Endometriosis 100%
2. Pregnancy 81%
3. Uterine Cervical Neoplasms 69%
4. Prenatal Diagnosis 61%
5. Neoplasms 59%
6. Fetus 59%
7. Genes 50%
8. Spermatozoa 48%
9. Ovarian Neoplasms 46%
10. Gestational Age 40%
11. Doppler Ultrasonography 31%
12. Spermatogenesis 30%
13. Fertilization in Vitro 29%
14. Stromal Cells 28%
15. Proteins 27%
16. Polycystic Ovary Syndrome 25%
17. Prader-Willi Syndrome 25%
18. Therapeutics 25%
19. Pre-Eclampsia 24%
20. Testis 24%
21. Ultrasonography 24%
22. Pregnant Women 24%
23. Placenta 23%
24. Down-Regulation 23%
25. Growth 23%
26. Hypoxia 22%
27. Ovarian Epithelial Carcinoma 21%
28. Y Chromosome 21%
29. Fetal Development 19%
30. Fetal Growth Retardation 19%
31. phthalic acid 19%
32. Survival 19%
33. Mutation 19%
34. Carcinogenesis 19%
35. Fertility 18%
36. Parturition 18%
37. Trophoblasts 18%
38. Quality of Life 17%
39. Vaccine Potency 17%
40. Endocrine-Gland-Derived Vascular Endothelial Growth Factor 17%
41. Germ Cells 17%
42. Single Nucleotide Polymorphism 17%
43. Pregnancy Outcome 16%
44. Endometrial Neoplasms 16%
45. Population 16%
46. Cohort Studies 16%
47. DNA 16%
48. Carcinoma 15%
49. Cystic Lymphangioma 15%
50. Fetal Weight 15%
51. Dinoprostone 15%
52. Serum 15%
53. Infertility 15%
54. Cell Proliferation 15%
55. Uterus 15%
56. Phosphorylation 15%
57. Dual Specificity Phosphatase 2 14%
58. Messenger RNA 14%
59. Microfluidics 14%
60. Embryo Transfer 14%
61. Sperm Motility 14%
62. Phenotype 13%
63. potassium-chloride symporters 13%
64. Methylation 13%
65. Drug Therapy 13%
66. Hyaluronic Acid 13%
67. Ovary 13%
68. Chromosomes 13%
69. Gonadotropin-Releasing Hormone 12%
70. Biomarkers 12%
71. Gestational Diabetes 12%
72. Somatomedins 12%
73. MicroRNAs 12%
74. Angelman Syndrome 12%
75. Hysterectomy 12%
76. Papanicolaou Test 12%
77. Umbilical Arteries 12%
78. Genotype 12%
79. Peritoneal Macrophages 12%
80. Karyotype 12%
81. Intellectual Disability 12%
82. Motor Vehicles 11%
83. Male sterility due to Y-chromosome deletions 11%
84. Cervix Uteri 11%
85. Mesenchymal Stem Cells 11%